ANI Pharmaceuticals Q1 2026 Earnings Major EPS Beat Belies Subdued Market Response KGS Q1 2026 Earnings EPS Surpasses Estimates by 109 Destination XL Group Q1 2026 Earnings Deep EPS Miss Sends Stock Lower Hologic HOLX Q1 2026 Earnings EPS Misses Estimates Amid Challenging Diagnostic Environment Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress Tyra Biosciences TYRA Q1 2026 Earnings Net Loss Slightly Wider Than Street Estimates